The Aedes aegypti toll pathway controls dengue virus infection

Zhiyong Xi1, Jose L Ramirez, George Dimopoulos

  • 1W. Harry Feinstone Department of Molecular Microbiology and Immunology, Bloomberg School of Public Health, Johns Hopkins University, Baltimore, Maryland, United States of America.

Plos Pathogens
|July 8, 2008
PubMed

Insights

Aedes aegypti mosquitoes use their innate immune system, particularly the Toll pathway, to fight dengue virus. The mosquito

Area of Science:

  • Vector-borne disease research
  • Immunology
  • Genomics

Background:

  • Aedes aegypti mosquitoes transmit dengue viruses, posing a significant global health threat.
  • Insect innate immunity, particularly against viruses, is primarily studied in Drosophila melanogaster.
  • Understanding Ae. aegypti's immune response is crucial for developing effective vector control strategies.

Purpose of the Study:

  • To characterize the innate immune response of Aedes aegypti to dengue virus infection.
  • To investigate the role of the Toll pathway in mosquito antiviral defense.
  • To assess the impact of the mosquito's endogenous microbiota on dengue virus infection.

Main Methods:

  • Whole-genome sequence analysis of Ae. aegypti.
  • High-throughput gene expression profiling.
  • RNA interference (RNAi)-based reverse genetics.
  • Analysis of dengue virus infection in different mosquito body compartments.
  • Assessment of mosquito endogenous microbial flora impact.

Main Results:

  • The Toll pathway plays a significant role in regulating resistance to dengue virus in Ae. aegypti.
  • Several Toll pathway-associated genes showed infection-responsive regulation and functional importance.
  • The mosquito's natural microbiota modulates dengue virus infection, potentially via basal Toll pathway stimulation.

Conclusions:

  • The Toll pathway is a key component of the Ae. aegypti innate immune response against dengue virus.
  • Mosquito microbiota influences dengue virus infection dynamics, highlighting a complex host-pathogen-microbe interaction.
  • These findings provide insights into mosquito antiviral immunity and potential targets for disease control.

Related Concept Videos

Murine Nasal Lavage Fluid Collection without Blood Contamination05:12

Murine Nasal Lavage Fluid Collection without Blood Contamination

The present protocol describes a novel method for avoiding blood contamination in murine nasal lavage fluid (NLF). Since this method ensures the NLF collection without blood contamination, it allows for more accurate detections of immunological components and various respiratory...
1.7K
Nasolacrimal Lavage as a Treatment for Ocular Surface Toxic Soup Syndrome03:40

Nasolacrimal Lavage as a Treatment for Ocular Surface Toxic Soup Syndrome

OSTSS leads to pooled inflammatory mediators in the tear film, causing symptoms like epiphora and discomfort. Here, we present a case where therapeutic nasolacrimal lavage every 2 months resolved epiphora and itchiness, suggesting its efficacy as a therapeutic intervention for OSTSS. Additionally, we report subjective improvements in symptoms in 3 additional...
1.1K
Saline Lavage for Sampling of the Canine Nasal Immune Microenvironment04:35

Saline Lavage for Sampling of the Canine Nasal Immune Microenvironment

Saline nasal lavage can be used to sample the canine nasal immune microenvironment. Because the approach is relatively non-invasive and does not disrupt the nasal tissues, it can be performed serially. Cells and proteins collected from the nasal lavage technique can be processed for various laboratory analyses.
880
Symptom Assessment of Patients with Allergic Rhinitis Using an Allergen Exposure Chamber08:47

Symptom Assessment of Patients with Allergic Rhinitis Using an Allergen Exposure Chamber

A protocol for conducting a challenge in an allergen exposure chamber (AEC) facility is presented. AECs have proven to be safe and effective tools for the induction of allergic symptoms or as an endpoint in the efficacy testing of allergen immunotherapy due to their ability to maintain stable particle concentrations and environmental...
2.9K
Reduced Itraconazole Concentration and Durations Are Successful in Treating Batrachochytrium dendrobatidis Infection in Amphibians06:49

Reduced Itraconazole Concentration and Durations Are Successful in Treating Batrachochytrium dendrobatidis Infection in Amphibians

Batrachochytrium dendrobatidis infection in amphibians can be eliminated using a reduced concentration (0.0025%) and shorter duration (five minute baths for six days) of itraconazole than is generally used. Less mortality and fewer negative side effects were observed using this modified treatment...
12.0K
Intranasal Administration of CNS Therapeutics to Awake Mice07:15

Intranasal Administration of CNS Therapeutics to Awake Mice

A method to intranasally administer drugs to awake mice for the purpose of targeting the brain is described. This method allows for repeat dosing over long periods using intranasal administration of drug without anesthesia, and nose-to-brain delivery with minimal systemic...
61.4K